Drug DiscoveryResearch & Development December 10, 2019 Merck to buy biopharmaceutical firm ArQule for $2.7bn By PBR Staff Writer ArQule is involved in the research and development of targeted therapeutics for the treatment of cancers and certain rare diseases. The company’s clinical-stage pipeline consists of four drug
Clinical TrialsHuman Trials December 2, 2019 Sensorion’s Seliforant to treat AUV fails to meet primary endpoint in phase 2b trial By PBR Staff Writer SENS-111 is an orally available small molecule histamine type 4 receptor antagonist, which delivers an inhibitory effect on vestibular neuron activity. According to the company, the SENS-111 was
Production & SalesManufacturing November 29, 2019 Novartis opens new cell and gene therapies facility in Switzerland By PBR Staff Writer The new facility also facilitates the production of advanced and difficult-to-manufacture solid dosage forms such as tablets and capsules, in addition to the manufacturing of novel CAR-T cell
Drug DiscoveryResearch & Development November 19, 2019 Alkermes to buy Rodin Therapeutics for up to $950m By PBR Staff Writer As per the terms of the deal, Rodin’s security holders will secure an upfront cash payment of $100m upon completion of the deal. Rodin is also eligible to
Drug DiscoveryResearch & Development November 18, 2019 Roche to buy clinical-stage biotechnology firm Promedior in $1.39bn deal By PBR Staff Writer As per terms of the merger deal, Promedior will secure an upfront cash payment of $390m, as well as additional contingent payments of up to $1bn based on
Production & SalesMarketing & Sales November 12, 2019 Novartis’ Sandoz to buy Aspen’s Japanese business in $441m deal By PBR Staff Writer The scope of the deal includes the acquisition of shares in Aspen Japan and associated assets held by Aspen Global. As per terms of the deal, Aspen will
Production & SalesManufacturing November 6, 2019 Japan’s Takeda opens dengue vaccine manufacturing facility in Germany By PBR Staff Writer The company will use the new manufacturing plant for formulation, fill, finish and secondary packaging of the TAK-003 tetravalent dengue vaccine candidate. Takeda started the initial construction activities
Drug DiscoveryResearch & Development October 10, 2019 NSF International purchases majority stake in Amarex CRO By PBR Staff Writer The acquisition of Amarex will help NSF to expand its consulting services to the medical device and pharma/biotech industries. Amarex will be included in NSF’s global health science
RegulationApprovals October 4, 2019 FDA approves Gilead’s HIV PrEP drug Descovy By PBR Staff Writer Descovy for PrEP has been approved to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing minimum 35kg who are HIV-negative and at-risk for
Production & SalesMarketing & Sales October 2, 2019 Servier acquires lymphoma drug Pixuvri from CTI BioPharma By PBR Staff Writer Pixuvri has approval for the treatment of adult patients having multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphoma, a type of blood cancer. The drug is a cytotoxic